CANF
Can-Fite BioPharma
CANF
CANF
11 hedge funds and large institutions have $1.87M invested in Can-Fite BioPharma in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$488K | |
| 2 | +$57.8K | |
| 3 | +$35K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$17K |
Top Sellers
| 1 | -$130K | |
| 2 | -$38.7K | |
| 3 | -$12K | |
| 4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2K |